<DOC>
	<DOCNO>NCT00705692</DOCNO>
	<brief_summary>Levamisole immunomodulator drug demonstrate improve immune response Hepatitis B virus ( HBV ) vaccination hemodialysis patient . The aim study evaluate effect levamisole supplementation tetanus-diphtheria ( Td ) vaccine response rate hemodialysis patient .</brief_summary>
	<brief_title>Effect Levamisole Supplementation Tetanus Vaccination Response Rates Hemodialysis Patients</brief_title>
	<detailed_description>Levamisole immunomodulator drug demonstrate improve immune response HBV vaccination hemodialysis patient . The aim study evaluate effect levamisole supplementation Td vaccine response rate hemodialysis patient . In randomized double-blind placebo-controlled trial 40 hemodialysis patient receive tetanus vaccination year investigation unprotective anti-tetanus immunoglobulin G ( IgG ) level ( &lt; 0.1 International Unit [ IU ] /ml ) enrol . These patient randomize two equal group receive one dose intramuscular Td vaccine supplement either levamisole 100 mg placebo daily , six day six day vaccination . The anti-tetanus IgG level measure 1 6 month vaccination .</detailed_description>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Levamisole</mesh_term>
	<criteria>regular hemodialysis 3 month unprotective baseline level antitetanus IgG tetanus diphtheria ( Td ) vaccination past year leukopenia ( WBC &lt; 1500 cells/mcL ) immunosuppressive drug exposure past 2 month recent hospitalization history transfusion blood product past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Tetanus</keyword>
	<keyword>Vaccines</keyword>
	<keyword>Renal Dialysis</keyword>
	<keyword>Levamisole</keyword>
</DOC>